Search

A recent study conducted at the University of Tabuk in Saudi Arabia focused on the effects of dates fruit on dyslipidemia among patients with Type-2 diabetes. The meta-analysis of randomized trials found that dates fruit consumption led to a reduction in total cholesterol levels, but did not significantly impact low-density lipoproteins, triglycerides, or high-density lipoproteins. The researchers concluded that further large-scale studies with a rigorous selection of controls and dates are necessary to validate these findings. [Extracted from the article]

Research conducted at the University of Tabuk in Saudi Arabia explored the association between insulin-like growth factor 2 mRNA-binding protein 2 (IGF2BP2) and interleukin-6 (IL-6) polymorphisms in type 2 diabetes mellitus (T2DM). The study involved 500 individuals, including obese T2DM cases and healthy controls, and found significant relationships between certain genetic variants and the risk of obese T2DM in the Saudi Arabian population. The study suggests a genetic model for identifying high-risk individuals and calls for further validation. [Extracted from the article]

Researchers from the University of Tabuk in Saudi Arabia have developed and optimized a formulation of losartan, an angiotensin II inhibitor, to improve its renal protective effects in type 2 diabetic patients. The formulation, called bilosomes, was found to have high drug entrapment efficiency, small vesicle size, and good colloidal stability. In an in vivo study using a diabetic nephropathy rats model, losartan bilosomes demonstrated improved kidney function, preserved renal cellular structure, and reduced inflammation and fibrosis compared to the free drug. These findings suggest that losartan bilosomes could be an effective oral formulation for mitigating diabetic nephropathy. [Extracted from the article]

Tabuk, Saudi Arabia, Asia, Emerging Technologies, Health and Medicine, Machine Learning, Nano-robot, Robotics, Robots Keywords: Tabuk; Saudi Arabia; Asia; Emerging Technologies; Health and Medicine; Machine Learning; Nano-robot; Robotics; Robots EN Tabuk Saudi Arabia Asia Emerging Technologies Health and Medicine Machine Learning Nano-robot Robotics Robots 85 85 1 04/24/23 20230424 NES 230424 2023 APR 24 (NewsRx) -- By a News Reporter-Staff News Editor at Diabetes Week -- Researchers detail new data in Robotics. [Extracted from the article]

Keywords: Tabuk; Saudi Arabia; Asia; Angiogenesis; Antidiabetic Agents; Biguanides; Diabetes Complications; Diabetes Mellitus; Diabetic Nephropathy; Drugs and Therapies; Health and Medicine; Hypoglycemic Agents; Intercellular Signaling Peptides and Proteins; Kidney Diseases and Conditions; Metformin; Metformin Therapy; Nephrology; Nephropathy; Non-Sulfonylureas; Nutritional and Metabolic Diseases and Conditions; Pharmaceuticals; Risk and Prevention; Transforming Growth Factors EN Tabuk Saudi Arabia Asia Angiogenesis Antidiabetic Agents Biguanides Diabetes Complications Diabetes Mellitus Diabetic Nephropathy Drugs and Therapies Health and Medicine Hypoglycemic Agents Intercellular Signaling Peptides and Proteins Kidney Diseases and Conditions Metformin Metformin Therapy Nephrology Nephropathy Non-Sulfonylureas Nutritional and Metabolic Diseases and Conditions Pharmaceuticals Risk and Prevention Transforming Growth Factors 2023 FEB 6 (NewsRx) -- By a News Reporter-Staff News Editor at Diabetes Week -- A new study on Kidney Diseases and Conditions - Diabetic Nephropathy is now available. Tabuk, Saudi Arabia, Asia, Angiogenesis, Antidiabetic Agents, Biguanides, Diabetes Complications, Diabetes Mellitus, Diabetic Nephropathy, Drugs and Therapies, Health and Medicine, Hypoglycemic Agents, Intercellular Signaling Peptides and Proteins, Kidney Diseases and Conditions, Metformin, Metformin Therapy, Nephrology, Nephropathy, Non-Sulfonylureas, Nutritional and Metabolic Diseases and Conditions, Pharmaceuticals, Risk and Prevention, Transforming Growth Factors. [Extracted from the article]